Use of preclinical models to improve treatment of retinoblastoma

被引：43
|
作者：
Dyer, MA
Rodriguez-Galindo, C
Wilson, MW
机构：
[1] Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN
[2] Department of Hematology Oncology, St. Jude Children's Research Hospital, Memphis, TN
[3] Department of Surgery, Division of Ophthalmology, St. Jude Children's Research Hospital, Memphis, TN
[4] Department of Ophthalmology, University of Tennessee, Health Science Center, Memphis, TN
来源：
PLOS MEDICINE | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1371/journal.pmed.0020332
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：971 / 976
页数：6
相关论文
共 50 条
  • [1] Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma
    Nemeth, Katie M.
    Federico, Sara
    Carcaboso, Angel M.
    Shen, Ying
    Schaiquevich, Paula
    Zhang, Jiakun
    Egorin, Merrill
    Stewart, Clinton
    Dyer, Michael A.
    CANCER, 2011, 117 (02) : 421 - 434
  • [2] The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma
    Sinenko, Irina L.
    Turnell-Ritson, Roland C.
    Munier, Francis L.
    Dyson, Paul J.
    EXPERIMENTAL EYE RESEARCH, 2023, 230
  • [3] AAV-mediated delivery of interferon-β for the treatment of retinoblastoma in preclinical models
    Shih, C.
    Laurie, N.
    Holzmacher, J.
    Davidoff, A.
    Dyer, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Preclinical analysis of hyperthermia for retinoblastoma treatment
    Ursea, R
    Silverman, RH
    Abramson, DH
    Coleman, DJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 3110 - 3110
  • [5] AAV-mediated Local Delivery of Interferon-β for the Treatment of Retinoblastoma in Preclinical Models
    Chie-Schin Shih
    Nikia Laurie
    Jeremy Holzmacher
    Yunyu Spence
    Amit C. Nathwani
    Andrew M. Davidoff
    Michael A. Dyer
    NeuroMolecular Medicine, 2009, 11
  • [6] AAV-mediated Local Delivery of Interferon-β for the Treatment of Retinoblastoma in Preclinical Models
    Shih, Chie-Schin
    Laurie, Nikia
    Holzmacher, Jeremy
    Spence, Yunyu
    Nathwani, Amit C.
    Davidoff, Andrew M.
    Dyer, Michael A.
    NEUROMOLECULAR MEDICINE, 2009, 11 (01) : 43 - 52
  • [7] EPIGENETIC THERAPY TARGETING SYK IN PRECLINICAL MODELS OF RETINOBLASTOMA
    Brennan, Rachel C.
    Stewart, Elizabeth
    Bradley, Cori
    Zhang, Jiakun
    Wilson, Matthew W.
    Stewart, Clinton
    Pritchard, Eleanor
    Zhu, Fangyi
    Guy, R. Kip
    Dyer, Michael A.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 989 - 989
  • [8] Efficacy and safety of Aflibercept in preclinical animal models of retinoblastoma
    Kim, Dong Yoon
    Hong, Ji Wook
    Choi, Jeong A.
    Yoon, Young Hee
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Recommendations for the use of preclinical models in the study and treatment of osteoarthritis
    Poole, R.
    Blake, S.
    Buschmann, M.
    Goldring, S.
    Laverty, S.
    Lockwood, S.
    Matyas, J.
    McDougall, J.
    Pritzker, K.
    Rudolphi, K.
    van den Berg, W.
    Yaksh, T.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S10 - S16
  • [10] Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment
    Hermine Mohr
    Alessia Foscarini
    Katja Steiger
    Simone Ballke
    Christoph Rischpler
    Franz Schilling
    Natalia S. Pellegata
    EJNMMI Research, 11
12345